Boom Capital
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Boom Capital.
Key people at Boom Capital.
Boom Capital is a San Francisco-based venture capital and private equity firm specializing in early-stage investments in deeply technical, under-networked founders who are building companies at the frontiers of science. Their mission is to identify and support transformative startups primarily in sectors such as healthcare, genomics, machine intelligence, aerospace, and new chemistries. The firm emphasizes a hands-on, operator-first approach to empower entrepreneurs, fostering growth and long-term partnerships that generate sustainable value for both portfolio companies and investors. Notable portfolio companies include Mammoth Biosciences and Fauna Bio, reflecting Boom Capital’s focus on cutting-edge scientific innovation[1][2].
Founded in 2017, Boom Capital was established with the goal of backing "scientist-protagonists" — founders with deep technical expertise but limited networks. The founding managing partner, Celestine “Cee Cee” Schnugg, leads the firm’s strategic focus on early-stage investments in science-driven ventures. Over time, Boom Capital has evolved to become a recognized early-stage investor in transformative startups, leveraging its extensive network and industry expertise to support founders from pre-seed through seed rounds primarily in North America[1][2][4].
Boom Capital rides the wave of increasing convergence between deep science and technology innovation, particularly in genomics, healthcare, machine intelligence, and aerospace. The timing is critical as advances in these fields are accelerating, creating opportunities for startups to disrupt traditional industries. Market forces such as growing demand for precision medicine, AI-driven solutions, and sustainable technologies align with Boom Capital’s investment thesis. By supporting under-networked scientist-founders, the firm helps democratize access to capital and expertise, influencing the broader ecosystem by enabling breakthrough innovations that might otherwise struggle to find early-stage funding[1][2][3].
Looking ahead, Boom Capital is poised to continue expanding its portfolio in frontier science sectors, capitalizing on emerging trends like synthetic biology, AI in healthcare, and aerospace technologies. Their recent fund activity, including a new fund opened in July 2025, suggests ongoing commitment to early-stage science ventures. As the scientific and technological landscape evolves, Boom Capital’s influence is likely to grow, further shaping the startup ecosystem by championing technically sophisticated founders and fostering innovations with the potential for significant societal impact[2][4]. This positions Boom Capital as a key player in bridging the gap between deep science and venture capital.
Key people at Boom Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2022 | Diligent Robotics | $30.0M Series B | — | Alumni Ventures, Austin Ventures, Canaan Partners, Capital Factory, DNX Ventures, Energy Impact Partners, Inspired Capital, Johnson, Jump Capital, LiveOak Venture Partners, Next Coast Ventures, OODA Ventures, Tiger Global Management, True Ventures, William Boebel |
| Sep 1, 2019 | Diligent Robotics | $3.0M Seed | — | Alumni Ventures, Austin Ventures, Canaan Partners, Capital Factory, DNX Ventures, Energy Impact Partners, Inspired Capital, Jump Capital, LiveOak Venture Partners, Next Coast Ventures, OODA Ventures, Tiger Global Management, True Ventures, William Boebel |
| Jan 1, 2018 | Diligent Robotics | $2.0M Seed | — | Alumni Ventures, Austin Ventures, Canaan Partners, Capital Factory, DNX Ventures, Energy Impact Partners, Inspired Capital, Jump Capital, LiveOak Venture Partners, Next Coast Ventures, OODA Ventures, Tiger Global Management, True Ventures, William Boebel |
